Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Gilead readies to file Sovaldi in Japan

03.04.2014 / Scripintelligence

Gilead Sciences has reported positive topline data from its Japanese Phase III trial of sofosbuvir (Sovaldi) in combination with ribavirin for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: